Nitric oxide as a mediator of parasympathetic vasodilation in ocular and extraocular tissues in the rabbit

Investigative Ophthalmology and Visual Science

Volumn 37, Issue 10, 1996, Pages 2110-2119

  Nilsson, Siv F E ^a,b  

^a UPPSALA UNIVERSITY   (Sweden)

^b Box 572 ^*  (Sweden)

Author keywords

blood flow; nitric oxide; parasympathetic nerves; retina; uvea

Indexed keywords

N(G) NITROARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; RADIOACTIVE MICROSPHERE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; EYE BLOOD FLOW; FACIAL NERVE; FEMALE; HEART OUTPUT; MALE; NERVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; RABBIT; UVEA; VASCULAR RESISTANCE; VASODILATATION;

ANIMALS; ARGININE; BLOOD FLOW VELOCITY; BLOOD PRESSURE; BLOOD VESSELS; ELECTRIC STIMULATION; ENZYME INHIBITORS; EYE; FACIAL NERVE; FEMALE; HARDERIAN GLAND; HEART RATE; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROARGININE; PARASYMPATHETIC NERVOUS SYSTEM; RABBITS; REGIONAL BLOOD FLOW; UVEA; VASODILATION;

EID: 0029743273     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Stone RA, Kuwayama Y. The nervous system and intraocular pressure. In: Ritch E, Shields MB, Krupin T, eds. The Glaucomas. St. Louis: CV Mosby; 1989:257-279.
2. Stjernschantz J, Bill A. Vasomotor effects of facial nerve stimulation: Noncholinergic vasodilation in the eye. Acta Physiol Scand. 1980;109:45-50.
3. Linder J. Effects of facial nerve section and stimulation on cerebral and ocular blood flow in hemorrhagic hypotension. Acta Physiol Scand. 1981;112:185-193.
4. Nilsson SFE, Linder J, Bill A. Characteristics of uveal vasodilation produced by facial nerve stimulation in monkeys, cats and rabbits. Exp Eye Res. 1985;40:841-852.
5. Stone RA, Kuwayama Y, Laties AM. Regulatory peptides in the eye. Experientia. 1987;43:791-800.
6. Butler JM, Ruskell GL, Cole DF, et al. Effects of VIIth (facial) nerve degeneration on vasoactive intestinal polypeptide and substance P levels in ocular and orbital tissues of the rabbit. Exp Eye Res. 1984;39:523-532.
7. Uddman R, Alumets J, Ehinger B, Håkanson R, Lorén I, Sundler F. Vasoactive intestinal peptide nerves in ocular and orbital structures of the cat. Invest Ophthalmol Vis Sci. 1980;19:878-885.
8. Nilsson SFE, Bill A. Vasoactive intestinal polypeptide (VIP) : Effects in the eye and on regional blood flows. Acta Physiol Scand. 1984;121:385-392.
9. Nilsson SFE, Mäepea O. Comparison of the vasodilatory effects of vasoactive intestinal polypeptide (VIP) and peptide-HI (PHI) in the rabbit and the cat. Acta Physiol Scand. 1987;129:17-26.
10. Bredt DS, Hwang PM, Snyder SH. Localization of nitric oxide synthase indicating a neuronal role for nitric oxide. Nature. 1990;347:768-770.
11. Hope BT, Michael GJ, Knigge KM, Vincent SR. Neuronal NADPH diaphorase is a nitric oxide synthase. Proc Natl Acad Sci. 1991;88:2811-2814.
12. Dawson TM, Bredt DS, Fotuhi M, Hwang PM, Snyder SH. Nitric oxide synthase and neuronal diaphorase are identical in brain and peripheral tissues. Proc Natl Acad Sci. 1991;88:7797-7801.
13. Yamamoto R, Bredt DS, Snyder SH, Stone RA. The localization of nitric oxide synthase in the rat eye and related cranial ganglia. Neuroscience. 1993;54:189-200.
14. Flügel C, Tamm ER, Mayer B, Lütjen-Drecoll E. Species differences in choroidal vasodilative innervation: Evidence for specific intrinsic nitrergic and VIP-positive neurons in the human eye. Invest Ophthalmol Vis Sci. 1994;35:592-599.
15. Toda N, Kitamura Y, Okamura T. Functional role of nerve-derived nitric oxide in isolated dog ophthalmic arteries. Invest Ophthalmol Vis Sci. 1995;36:563-570.
16. Toda N, Ayajiki K, Yoshida K, Kimura H, Okamura T. Impairment by damage of the pterygopalatine ganglion of nitroxidergic vasodilator nerve function in canine cerebral and retinal arteries. Circ Res. 1993; 72:206-213.
17. Wiencke AK, Nilsson H, Nielsen PJ, Nyborg NCB. Nonadrenergic noncholinergic vasodilation in bovine ciliary artery involves CGRP and neurogenic nitric oxide. Invest Ophthalmol Vis Sci. 1994;35:3268-3277.
18. Nyborg NCB, Nielsen PJ. Neurogenic nitric oxide accounts for the non-adrenergic non-cholinergic vasodilation in human posterior ciliary arteries. ARVO Abstracts. Invest Ophthalmol Vis Sci. 1994;34:1287.
19. G-nitro L-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists. Circ Res. 1993;72:387-395.
20. Alm A, Bill A. The oxygen supply to the retina: II: Effects of high intraocular pressure and of increased arterial carbon dioxide tension on uveal and retinal blood flow in cats: A study with radioactively labelled microspheres including flow determinations in brain and some other tissues. Acta Physiol Scand. 1972; 84:306-319.
21. Hillerdal M, Sperber GO, Bill A. The microsphere method for measuring low blood flows: Theory and computer simulations applied to findings in the rat cochlea. Acta Physiol Scand. 1987;130:229-235.
22. Stjernschantz J, Alm A, Bill A. Effects of oculomotor nerve stimulation on ocular blood flow in rabbits: Modification by indomethacin. Exp Eye Res. 1976; 23:461-469.
23. Nilsson SFE. Neuropeptide Y (NPY): A vasoconstrictor in the eye, brain and other tissues in the rabbit. Acta Physiol Scand. 1991;141:455-467.
24. Bill A. Circulation in the eye. In: Renkin EM, Michel CC, Geiger SR, eds. Handbook of Physiology - The Cardiovascular System TV. Bethesda, MD: American Physiological Society; 1984:1001-1034.
25. Toda N, Kitamura Y, Okamura T. Role of nitroxidergic nerve in dog retinal arterioles in vivo and arteries in vitro. Am J Physiol. 1994;266:H1985-H1992.
26. Edwards AV, Garrett JR. Nitric oxide-related vasodilator responses to parasympathetic stimulation of the submandibular gland in the cat. J Physiol. 1993; 464:379-392.
27. G-nitro-L-arginine on sympathetic and parasympathetic vascular control in vivo. Neuroscience. 1994;62:189-203.
28. Persson MG, Wiklund NP, Gustafsson LE. Nitric oxide requirement for vasomotor nerve-induced vasodilation and modulation of resting blood flow in the muscle microcirculation. Acta Physiol Scand. 1991;141:49-56.
29. Mulder H, Uddman R, Moller K, et al. Pituitary adenylate cyclase activating polypeptide is expressed in autonomic neurons. Regul Peptides. 1995;59:121-128.
30. Moller K, Zhang Y-Z, Håkanson R, et al. Pituitary adenylate cyclase activating peptide is a sensory neuropeptide: Immunocytochemical and immunochemical evidence. Neuroscience. 1993;57:725-732.
31. Wang ZY, Alm P, Håkanson R. Distribution and effects of pituitary adenylate cyclase activating polypeptide in the rabbit eye. Neuroscience. 1995;69:297-308.
32. Nilsson SFE. PACAP-27 and PACAP-38: Vascular effects in the eye and some other tissues in the rabbit. Eur J Pharmacol. 1994;253:17-25.
33. Nilsson SFE, De Neef P, Robberecht P, Christophe J. Characterization of ocular receptors for pituitary adenylate cyclase activating polypeptide (PACAP) and their coupling to adenylate cyclase. Exp Eye Res. 1994;58:459-467.
34. Bakken IJ, Vincent MB, Sjaavaag I, White LR. Vasodilation in porcine ophthalmic artery: Peptide interaction with acetylcholine and endothelial dependence. Neuropeptides. 1995;29:69-75.
35. Nyborg NCB, Nielsen PJ, Wiencke AK. Vasoactive intestinal polypeptide (VIP) preferentially dilates intraocular branches of the anterior ciliary artery supplying the ciliary body in bovine eyes. Acta Physiol Scand. 1992;146(suppl 608):140.
36. Lundberg JM, Änggård A, Fahrenkrug J. Complementary role of vasoactive intestinal polypeptide (VIP) and acetylcholine for cat submandibular blood flow and secretion: II: Effects of cholinergic antagonists and VIP antisenim. Acta Physiol Scand. 1981;113:329-336.
37. Lundberg JM, Änggård A, Emson P, Fahrenkrug J, Hökfelt T. Vasoactive intestinal polypeptide and cholinergic mechanisms in cat nasal mucosa: studies on choline acetyltransferase and release of vasoactive intestinal polypeptide. Proc Natl Acad Sci. 1981;78:5255-5259.
38. G-nitro-L-arginine methyl ester on the cardiovascular system of the anaesthetized rabbit and on the cardiovascular response to thyrotropin-releasing hormone. Br J Pharmacol. 1993; 109:1219-1225.
39. Granstam E, Wang L, Bill, A. Vascular effects of endothelin-1 in the cat: Modification by indomethacin and L-NAME. Acta Physiol Scand. 1993;148:165-170.
40. Mann RM, Riva CE, Stone RA, Barnes GE, Cranstoun SD. Nitric oxide and choroidal blood flow regulation. Invest Ophthalmol Vis Sci. 1995;36:925-930.
41. Deussen A, Sonntag M, Vogel R. L-arginine-derived nitric oxide: a major determinant of uveal blood flow. Exp Eye Res. 1993;57:129-134.
42. Jacot JL, O'Neill JT, Scandling DM, West SD, McKenzie JE. Role of nitric oxide in modulating retinal choroidal and anterior uveal blood flow in piglets. ARVO Abstracts. Invest Ophthalmol Vis Sci. 1994;35:1288.
43. Gidday JM, Zhu Y. Nitric oxide does not mediate autoregulation of retinal blood flow in the newborn pig. Am J Physiol. 1995;269:H1065-H1072.
44. Donati G, Pournaras CJ, Munoz J-L, Poitry S, Poitry-Yamate CL, Tsacopoulos M. Nitric oxide controls arteriolar tone in the retina of the miniature pig. Invest Ophthalmol Vis Sci. 1995;36:2228-2237.
45. Riva CE, Harino S, Shonat RD, Petrig BL. Flicker evoked increase in optic nerve head blood flow in anesthetized cats. Neurosci Lett. 1991;128:291-296.
46. Wang L, Kondo M, Bill A. Vascular responses to flickering light in the retina in cats and monkeys: Effect of L-NAME. Acta Physiol Scand. 1995;153:39A.